These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16777619)

  • 41. [Place of CSF in pediatric oncology].
    Hartmann O; Valteau-Couanet D
    Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
    [No Abstract]   [Full Text] [Related]  

  • 42. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 43. Hematopoietic growth factors in pediatrics.
    Frenck RW; Shannon KM
    Curr Opin Pediatr; 1993 Feb; 5(1):94-102. PubMed ID: 7690636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 45. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
    Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
    [No Abstract]   [Full Text] [Related]  

  • 46. [Hematopoietic tissue growth factors: clinical factors].
    Polli EE; Foa P
    Ann Ital Med Int; 1991; 6(1 Pt 1):69-81. PubMed ID: 1716450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
    Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
    Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.
    Croockewit AJ; Bronchud MH; Aapro MS; Bargetzi MJ; Crown J; Gratwohl A; Lange W; Ludwig H; Martinelli G; Mertelsmann R; Nuessler V; Willemze R; De Witte TJ; Zittoun R; Zwierzina H
    Eur J Cancer; 1997 Oct; 33(11):1732-46. PubMed ID: 9470826
    [No Abstract]   [Full Text] [Related]  

  • 50. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
    Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M
    Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397
    [No Abstract]   [Full Text] [Related]  

  • 51. The benefits of haematopoietic growth factors in the management of gynaecological oncology.
    Dale DC
    Eur J Gynaecol Oncol; 2004; 25(2):133-44. PubMed ID: 15032269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colony-stimulating factor use in the context of refined risk and benefit assessments.
    Crawford J
    Oncology (Williston Park); 2006 Apr; 20(5 Suppl 4):9-10. PubMed ID: 16736982
    [No Abstract]   [Full Text] [Related]  

  • 53. Hematopoietic growth factors for chemotherapy-induced neutropenia.
    Yalçin S
    Cancer Invest; 1999; 17(7):555-6. PubMed ID: 10518202
    [No Abstract]   [Full Text] [Related]  

  • 54. Hemopoietic growth factors: a review.
    Rowe JM; Rapoport AP
    J Clin Pharmacol; 1992 Jun; 32(6):486-501. PubMed ID: 1378857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetic stem-cell "mobilopathy".
    DiPersio JF
    N Engl J Med; 2011 Dec; 365(26):2536-8. PubMed ID: 22204729
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical applications of hematopoietic growth factors in pediatric oncology.
    Levine JE; Boxer LA
    Curr Opin Hematol; 2002 May; 9(3):222-7. PubMed ID: 11953668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indications and guidelines for the use of hematopoietic growth factors.
    Goodnough LT; Anderson KC; Kurtz S; Lane TA; Pisciotto PT; Sayers MH; Silberstein LE
    Transfusion; 1993; 33(11):944-59. PubMed ID: 7505068
    [No Abstract]   [Full Text] [Related]  

  • 58. Hematopoietic growth factors for the treatment of aplastic anemia.
    Kumar M; Alter BP
    Curr Opin Hematol; 1998 May; 5(3):226-34. PubMed ID: 9664165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New generation cytokines to prevent anemia and febrile neutropenia].
    Fayette J; Blay JY
    Bull Cancer; 2006 May; 93(5):483-7. PubMed ID: 16777626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colony-stimulating factors stimulate some treatments, continue to evolve.
    Volkers N
    J Natl Cancer Inst; 1999 Feb; 91(3):210-2. PubMed ID: 10037097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.